Shijie Ren

Has grant

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Improving the robustness of health technology funding decisions when evidence is from single-arm trials

Open Date: 2021-01-01

Close Date: 2024-12-31

Grant: Close

Pembrolizumab for locally advanced or metastatic urothelial cancer where cisplatin is unsuitable [ID1209]

Open Date: 2017-11-30

Close Date: 2018-03-08

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Nicky J Welton

University of Bristol

UNITED KINGDOM

View details

Steven Julious

University of Sheffield

UNITED KINGDOM

View details

Mark Strong

Professor of Public Health and Deputy Dean of ScHARR

University of Sheffield

UNITED KINGDOM

View details

Marta Buszewicz

University College London

UNITED KINGDOM

View details

Robert Smith

University of Sheffield

UNITED KINGDOM

View details

Bram Ramaekers

Maastricht University Medical Centre

NETHERLANDS

View details

Praveen Thokala

University of Sheffield

UNITED KINGDOM

View details

John Stevens

Reader in Decision Science

University of Sheffield

UNITED KINGDOM

View details

Steve Goodacre

University of Sheffield

UNITED KINGDOM

View details

Munira Essat

University of Sheffield

UNITED KINGDOM

View details

Joanna Leaviss

University of Sheffield

UNITED KINGDOM

View details

Glenys Parry

Professor of Psychological Therapies

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shijie Ren

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)

MCL-509 Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)

Diagnostic accuracy of the aortic dissection detection risk score alone or with D-dimer for acute aortic syndromes: systematic review and meta-analysis

Diagnostic accuracy of D-dimer for acute aortic syndromes: systematic review and meta-analysis

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Issues, challenges and opportunities for economic evaluations of orphan drugs in rare diseases: an umbrella review

SA46 Are We Dealing With Heterogeneity in Network Meta-Analysis Appropriately? A Review of NICE Submissions

Advancing unanchored simulated treatment comparisons: a novel implementation and simulation study

Rate of complete spectacle independence with a trifocal intraocular lens: a systematic literature review and meta-analysis

Living health technology assessment: issues, challenges and opportunities

MSR159 A Novel Unanchored Simulated Treatment Comparison Approach for Time-to-Event Data

SA80 Priors on Between-Study Heterogeneity in Bayesian Meta-Analysis Models: A Simulation Study Using Hamiltonian Monte Carlo Sampling

An investigation of the constancy of effect in Cochrane systematic reviews in context with the assumptions for noninferiority trials

The cost-effectiveness of belimumab and voclosporin for patients with Lupus Nephritis in the United States

Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation

Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US

R and Shiny for cost-effectiveness analyses : why and when? A hypothetical case study

How uncertain is the survival extrapolation? A study of the impact of different parametric survival models on extrapolated uncertainty about hazard functions, lifetime mean survival and cost effectiveness

Collaborators (12)

Nicky J Welton

Steven Julious

Mark Strong

Marta Buszewicz

Robert Smith

Bram Ramaekers

Praveen Thokala

John Stevens

Steve Goodacre

Munira Essat

Joanna Leaviss

Glenys Parry

Make your next move.